has role bleomycin bacterial metabolite bleomycin A5 1439.592 1440.56100 A member of the class of bleomycins that is used in sclerotherapy for cervicofacial lymphatic malformations. BLM A5 Bleomycetin C57H89N19O21S2 CAS:11116-32-8 CHEBI:78160 C[C@@H](O)[C@H](NC(=O)[C@@H](C)[C@H](O)[C@@H](C)NC(=O)[C@@H](NC(=O)c1nc(nc(N)c1C)[C@H](CC(N)=O)NC[C@H](N)C(N)=O)[C@@H](O[C@@H]1O[C@@H](CO)[C@@H](O)[C@H](O)[C@@H]1O[C@H]1O[C@H](CO)[C@@H](O)[C@H](OC(N)=O)[C@@H]1O)c1c[nH]cn1)C(=O)NCCc1nc(cs1)-c1nc(cs1)C(=O)NCCCNCCCCN InChI=1S/C57H89N19O21S2/c1-22-35(73-48(76-46(22)61)27(14-33(60)80)68-15-26(59)47(62)86)52(90)75-37(43(28-16-65-21-69-28)95-56-45(41(84)39(82)31(17-77)94-56)96-55-42(85)44(97-57(63)92)40(83)32(18-78)93-55)53(91)70-24(3)38(81)23(2)49(87)74-36(25(4)79)51(89)67-13-8-34-71-30(20-98-34)54-72-29(19-99-54)50(88)66-12-7-11-64-10-6-5-9-58/h16,19-21,23-27,31-32,36-45,55-56,64,68,77-79,81-85H,5-15,17-18,58-59H2,1-4H3,(H2,60,80)(H2,62,86)(H2,63,92)(H,65,69)(H,66,88)(H,67,89)(H,70,91)(H,74,87)(H,75,90)(H2,61,73,76)/t23-,24+,25+,26-,27-,31-,32+,36-,37-,38-,39+,40+,41-,42-,43-,44-,45-,55+,56-/m0/s1 N1-(3-((4-Aminobutyl)amino)propyl)bleomycinamide PMID:14675139 PMID:19740258 PMID:20843632 PMID:22378834 PMID:22932480 PMID:23073810 PMID:23236562 PMID:23257316 PMID:23426884 PMID:23508003 PMID:23534516 PMID:23603483 PMID:23708035 PMID:23708044 PMID:23848975 PMID:23898618 PMID:23953485 PMID:24396428 PMID:24504597 PMID:24604118 Pingyangmycin QYOAUOAXCQAEMW-UTXKDXHTSA-N Reaxys:8386869 Zhengguangmycin A5 chebi_ontology